BlackRock Inc. - X4 PHARMACEUTICALS INC ownership

X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 51 filers reported holding X4 PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 1.30 and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of X4 PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$8,890,957
-49.6%
8,156,841
-10.3%
0.00%
Q2 2023$17,644,831
+5803.0%
9,095,274
+2547.2%
0.00%
Q1 2023$298,914
+9.6%
343,580
+25.1%
0.00%
Q4 2022$272,763
-44.8%
274,686
-5.1%
0.00%
Q3 2022$494,000
+84.3%
289,383
+4.3%
0.00%
Q2 2022$268,000
-43.7%
277,453
+2.1%
0.00%
Q1 2022$476,000
-24.2%
271,794
-1.0%
0.00%
Q4 2021$628,000
-55.7%
274,548
+2.3%
0.00%
Q3 2021$1,419,000
-17.1%
268,450
+2.0%
0.00%
Q2 2021$1,711,000
-81.8%
263,290
-75.9%
0.00%
Q1 2021$9,399,000
+41.4%
1,091,753
+5.6%
0.00%
Q4 2020$6,645,000
-0.5%
1,033,503
+4.8%
0.00%
Q3 2020$6,677,000
-26.4%
986,193
+1.4%
0.00%
Q2 2020$9,069,000
+3.6%
973,038
+11.1%
0.00%
Q1 2020$8,755,000
+2.3%
875,549
+9.5%
0.00%
Q4 2019$8,554,000
-4.8%
799,579
+13.1%
0.00%
Q3 2019$8,984,000
+31.2%
706,907
+54.9%
0.00%
Q2 2019$6,847,000
+886.6%
456,495
+1044.8%
0.00%
Q1 2019$694,00039,8770.00%
Other shareholders
X4 PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 12,202,510$10,6161.33%
Tri Locum Partners LP 3,878,484$3,374,2811.03%
Lynwood Capital Management Inc. 900,000$783,0000.71%
NEA Management Company, LLC 11,736,793$10,211,0100.71%
Parkman Healthcare Partners LLC 2,797,147$2,433,5180.53%
SCOGGIN MANAGEMENT LP 484,796$567,0250.33%
New Leaf Venture Partners, L.L.C. 335,000$291,4500.24%
Ghost Tree Capital, LLC 850,000$740,0000.22%
Perceptive Advisors 4,545,454$3,954,5450.12%
Orbimed Advisors 5,817,726$5,061,4220.10%
View complete list of X4 PHARMACEUTICALS INC shareholders